Cite
HARVARD Citation
Angelidou, A. et al. (2020). Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation. Vaccine. 38 (9), pp. 2229-2240. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Angelidou, A. et al. (2020). Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation. Vaccine. 38 (9), pp. 2229-2240. [Online].